Goflikicept, CAS 2416984-26-2

Product Description: Goflikicept (RPH 104) is a hybrid protein that selectively binds and inactivates both circulating IL-1ß and IL-1α. Goflikicept has the potential for the research of ST-segment elevation myocardial infarction (STEMI)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Samsonov M, et al. Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale. J Transl Med. 2021 Apr 26;19(1):169.

CAS Number: 2416984-26-2

Molecular Weight: N/A

Compound Purity: 98.32

Research Area: Inflammation/Immunology; Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99645-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99645-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated